Medicinova (MNOV) Accumulated Expenses (2010 - 2026)

Medicinova (MNOV) has reported Accumulated Expenses for 16 consecutive years, with $2.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Accumulated Expenses rose 56.84% year-over-year to $2.6 million; the TTM figure through Dec 2025 stood at $2.6 million (up 56.84% YoY), while the FY2025 annual figure was $2.6 million, up 56.84% from the prior year.
• Accumulated Expenses rose to $2.6 million in Q4 2025 per MNOV's latest filing, from $1.9 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $3.8 million in Q3 2022 and bottomed at $636481.0 in Q4 2021.
• Historically, Accumulated Expenses has averaged $1.8 million across 5 years, with a median of $1.8 million in 2021.
• Annual changes were most pronounced in 2021 — Accumulated Expenses sank 54.25% — and 2022, when it soared 122.09%.
• Medicinova's Accumulated Expenses stood at $636481.0 in 2021, then soared by 44.57% to $920166.0 in 2022, then fell by 10.41% to $824390.0 in 2023, then surged by 101.71% to $1.7 million in 2024, then soared by 56.84% to $2.6 million in 2025.
• Business Quant data shows MNOV's Accumulated Expenses at $2.6 million in Q4 2025, $1.9 million in Q3 2025, and $1.9 million in Q2 2025.